Dr. Krie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 E 28th St
Ste 404
Minneapolis, MN 55407Phone+1 612-863-0200Fax+1 612-863-0235
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2001 - 2004
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2001
Certifications & Licensure
- OR State Medical License 2003 - Present
- MN State Medical License 2020 - 2025
- IA State Medical License 2004 - 2022
- SD State Medical License Active through 2021
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
- Most Compassionate Doctor American Registry
Clinical Trials
- Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer Start of enrollment: 2006 Oct 12
- A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Start of enrollment: 2012 Oct 03
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- Join now to see all
Publications & Presentations
PubMed
- Breast Cancer Polygenic Risk Score Validation and Effects of Variable Imputation.Jeffrey J Beck, John L Slunecka, Brandon N Johnson, Austin J Van Asselt, Casey T Finnicum
Cancers. 2024-04-20 - 46 citationsMolecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.Jason K. Sicklick, Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam
Genome Medicine. 2021-10-04 - 2 citationsCase report: 16-yr life history and genomic evolution of an ER+ HER2- breast cancer.Bing Xu, Anu Amallraja, Padmapriya Swaminathan, Rachel Elsey, Christel M. Davis
Cold Spring Harbor Molecular Case Studies. 2020-12-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: